The First Fatal Intoxication with 3-MeO-PCP in the UK and a Review of the Literature.
Journal of Analytical Toxicology May 20, 2022 Caroline S Copeland, Simon Hudson, Ric Treble et al. 9 citations
The dissociative hallucinogen 3-MeO-PCP, a phencyclidine derivative, can cause severe psychological agitation and life-threatening cardiorespiratory effects. The United Nations classified it as a Schedule II substance in 2021. This report describes the first UK fatality solely attributable to 3-MeO-PCP intoxication, adding to 15 previous fatal cases worldwide. The authors note that blood concentrations associated with toxicity remain uncertain but provide detailed sample information to aid future interpretation. They suggest that exercise may worsen toxicity, cautioning against use as a club drug where elevated heart rate, body temperature, and blood pressure are likely.